It is also sometimes prescribed off-label (for a non-FDA-approved use) for weight loss
These follow-on patents, also known as secondary patents, mainly consist of formulations, combinations with other drugs, methods of treating different indications that were alreadydisclosed in the main compound patents, and drug delivery devices
Melanin Inhibitor (8,000 mg) : Prevents dark spots and promotes an even skin tone
Concerns about the potential association between certain diabetes medications and cardiovascular disease meant that in 2010 the FDA approved liraglutide on condition that Novo Nordisk conduct a post-marketing study to evaluate the drug's effect on the incidence of major cardiovascular events (Nielsen, DeChiaro, Goldman)
They further proposed that NOS mRNA is also a factor involved in the process of oxidative stress in patients with cortical cataracts and has a certain effect on the progression of cataracts